Henry Schein Q4 2024 Earnings Report
Key Takeaways
Henry Schein Inc. delivered a solid fourth quarter, achieving a 5.8% increase in total net sales. GAAP net income surged to $94 million, and non-GAAP net income increased to $149 million. Adjusted EBITDA also rose significantly to $270 million, reflecting strong operational performance. The company’s restructuring efforts contributed to cost efficiencies, supporting future growth.
Total net sales increased 5.8% year-over-year to $3.19 billion.
GAAP net income reached $94 million, with non-GAAP net income at $149 million.
Adjusted EBITDA improved to $270 million from $172 million in Q4 2023.
Strong sales growth across Global Dental and Specialty Products segments.
Henry Schein Revenue
Henry Schein EPS
Henry Schein Revenue by Segment
Henry Schein Revenue by Geographic Location
Forward Guidance
Henry Schein expects moderate growth in 2025, with total sales projected to increase by 2-4% and non-GAAP EPS ranging between $4.80 and $4.94.
Positive Outlook
- Total sales growth forecasted at 2-4% for FY 2025.
- Non-GAAP diluted EPS expected between $4.80 and $4.94.
- Adjusted EBITDA projected to grow in mid-single digits.
- Continued benefits from restructuring and operational efficiencies.
- Strong outlook for specialty products and technology solutions.
Challenges Ahead
- Foreign currency fluctuations may impact revenue growth.
- Macroeconomic uncertainty could influence demand.
- Ongoing restructuring costs may weigh on short-term profitability.
- Potential cybersecurity risks remain a concern.
- Competitive pressures in the medical and dental markets.
Revenue & Expenses
Visualization of income flow from segment revenue to net income